Current and experimental treatments of Parkinson disease: A guide for neuroscientists

W Oertel, JB Schulz - Journal of neurochemistry, 2016 - Wiley Online Library
Over a period of more than 50 years, the symptomatic treatment of the motor symptoms of
Parkinson disease (PD) has been optimized using pharmacotherapy, deep brain …

Smoking, nicotine and neuropsychiatric disorders

P Dome, J Lazary, MP Kalapos, Z Rihmer - Neuroscience & Biobehavioral …, 2010 - Elsevier
Tobacco smoking is an extremely addictive and harmful form of nicotine (NIC) consumption,
but unfortunately also the most prevalent. Although disproportionately high frequencies of …

C. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During Aging

TJ Van Ham, KL Thijssen, R Breitling… - PLoS …, 2008 - journals.plos.org
Inclusions in the brain containing α-synuclein are the pathological hallmark of Parkinson's
disease, but how these inclusions are formed and how this links to disease is poorly …

α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease

M Quik, S Wonnacott - Pharmacological reviews, 2011 - ASPET
Parkinson's disease is a debilitating movement disorder characterized by a generalized
dysfunction of the nervous system, with a particularly prominent decline in the nigrostriatal …

2011 CCNP Heinz Lehmann Award paper: Cytochrome P450–mediated drug metabolism in the brain

S Miksys, RF Tyndale - Journal of Psychiatry and Neuroscience, 2013 - jpn.ca
Cytochrome P450 enzymes (CYPs) metabolize many drugs that act on the central nervous
system (CNS), such as antidepressants and antipsychotics; drugs of abuse; endogenous …

Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease

F Simunovic, M Yi, Y Wang, R Stephens, KC Sonntag - PloS one, 2010 - journals.plos.org
Background Epidemiological data suggest that the male gender is one of the risks factors for
the development of Parkinson Disease (PD). Also, differences in the clinical manifestation …

Multiple roles for nicotine in Parkinson's disease

M Quik, LZ Huang, N Parameswaran, T Bordia… - Biochemical …, 2009 - Elsevier
There exists a remarkable diversity of neurotransmitter compounds in the striatum, a pivotal
brain region in the pathology of Parkinson's disease, a movement disorder characterized by …

Nicotine from cigarette smoking and diet and Parkinson disease: a review

C Ma, Y Liu, S Neumann, X Gao - Translational neurodegeneration, 2017 - Springer
Evidence from epidemiological studies suggest a relationship between cigarette smoking
and low risk of Parkinson disease (PD). As a major component of tobacco smoke, nicotine …

[HTML][HTML] Harmaline tremor: underlying mechanisms in a potential animal model of essential tremor

A Handforth - Tremor and other hyperkinetic movements, 2012 - ncbi.nlm.nih.gov
Background Harmaline and harmine are tremorigenic β-carbolines that, on administration to
experimental animals, induce an acute postural and kinetic tremor of axial and truncal …

Nicotine and inflammatory neurological disorders

WH Piao, D Campagnolo, C Dayao, RJ Lukas… - Acta Pharmacologica …, 2009 - nature.com
Cigarette smoke is a major health risk factor which significantly increases the incidence of
diseases including lung cancer and respiratory infections. However, there is increasing …